Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016–2021 Data

  25 April 2024

A study analyzing the appropriateness of US outpatient antibiotic prescribing after the COVID-19 outbreak found that the proportion of enrollees with ≥1 inappropriate prescription decreased in March 2020 but increased in December 2021. The study used Optum’s Clinformatics Data Mart Database, a national commercial and Medicare Advantage claims database, to assess the impact of the outbreak. The results suggest that despite initial decline, the proportion of enrollees exposed to inappropriate antibiotics returned to baseline levels by December 2021, emphasizing the importance of outpatient antibiotic stewardship initiatives.

Author(s): Kao-Ping Chua et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed